Literature DB >> 32008390

Personalizing the Treatment of Substance Use Disorders.

Nora D Volkow1.   

Abstract

Keywords:  Alcohol Use Disorder; Nicotine Use Disorder; Opioid Use Disorder; Substance Use Disorder Treatment

Mesh：

Year:  2020        PMID： 32008390     DOI： 10.1176/appi.ajp.2019.19121284

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  23 in total

1.  Digital Health and Addiction.

Authors:  Lisa A Marsch
Journal:  Curr Opin Syst Biol       Date:  2020-07-07

2.  Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.

Authors:  James H Ford; Arveen Kaur; Deepika Rao; Aaron Gilson; Daniel M Bolt; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  Implement Res Pract       Date:  2021-09-17

Review 3.  Expanding the continuum of substance use disorder treatment: Nonabstinence approaches.

Authors:  Catherine E Paquette; Stacey B Daughters; Katie Witkiewitz
Journal:  Clin Psychol Rev       Date:  2021-11-26

Review 4.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

5.  Applying methods for personalized medicine to the treatment of alcohol use disorder.

Authors:  Alena Kuhlemeier; Yasin Desai; Alexandra Tonigan; Katie Witkiewitz; Thomas Jaki; Yu-Yu Hsiao; Chi Chang; M Lee Van Horn
Journal:  J Consult Clin Psychol       Date:  2021-04

6.  Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.

Authors:  Mary A Hatch-Maillette; K Michelle Peavy; Judith I Tsui; Caleb J Banta-Green; Stephen Woolworth; Paul Grekin
Journal:  J Subst Abuse Treat       Date:  2020-12-05

7.  Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.

Authors:  Nicholas Lintzeris; Adrian J Dunlop; Paul S Haber; Dan I Lubman; Robert Graham; Sarah Hutchinson; Shalini Arunogiri; Victoria Hayes; Peter Hjelmström; Agneta Svedberg; Stefan Peterson; Fredrik Tiberg
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 8.  Tobacco and nicotine use.

Authors:  Bernard Le Foll; Megan E Piper; Christie D Fowler; Serena Tonstad; Laura Bierut; Lin Lu; Prabhat Jha; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2022-03-24       Impact factor: 52.329

9.  Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.

Authors:  Lara N Coughlin; Paul Pfeiffer; Dara Ganoczy; Lewei A Lin
Journal:  Am J Psychiatry       Date:  2020-10-29       Impact factor: 18.112

10.  Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial.

Authors:  Christopher S Stauffer; Jenna M Moschetto; Scott McKernan; Nathan Meinzer; Chavy Chiang; Rachel Rapier; Elaine Hsiang; Jerika Norona; Brian Borsari; Joshua D Woolley
Journal:  J Subst Abuse Treat       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.